Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Knowledge, skills and attitudes related to evidence-based practice among undergraduate nursing students: A survey at three universities in Colombia, Chile and Spain.

Sánchez-García I, Ureña Molina MDP, López-Medina IM, Pancorbo-Hidalgo PL.

Nurse Educ Pract. 2019 Aug 20;39:117-123. doi: 10.1016/j.nepr.2019.08.009. [Epub ahead of print]

PMID:
31449990
2.

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.

Parvin S, Ramirez-Labrada A, Aumann S, Lu X, Weich N, Santiago G, Cortizas EM, Sharabi E, Zhang Y, Sanchez-Garcia I, Gentles AJ, Roberts E, Bilbao-Cortes D, Vega F, Chapman JR, Verdun RE, Lossos IS.

Cancer Cell. 2019 Aug 12. pii: S1535-6108(19)30334-4. doi: 10.1016/j.ccell.2019.07.007. [Epub ahead of print]

PMID:
31447348
3.

Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.

Jiang X, Lu X, Zhang Y, Lacaria L, Schuchardt BJ, Mikles DC, Magistri M, García-Ramírez I, Sanchez-Garcia I, Farooq A, Verdun RE, Abdulreda MH, Moy VT, Lossos IS.

Blood Adv. 2019 Aug 13;3(15):2286-2297. doi: 10.1182/bloodadvances.2018016162.

4.

Novel ETV6-RUNX1 Mouse Model to Study the Role of ELF-MF in Childhood B-Acute Lymphoblastic Leukemia: a Pilot Study.

Campos-Sanchez E, Vicente-Dueñas C, Rodríguez-Hernández G, Capstick M, Kuster N, Dasenbrock C, Sánchez-García I, Cobaleda C.

Bioelectromagnetics. 2019 Jul;40(5):343-353. doi: 10.1002/bem.22193. Epub 2019 Jun 3.

PMID:
31157932
5.

Measuring knowledge of Alzheimer's: development and psychometric testing of the UJA Alzheimer's Care Scale.

Parra-Anguita L, Sánchez-García I, Del Pino-Casado R, Pancorbo-Hidalgo PL.

BMC Geriatr. 2019 Mar 4;19(1):63. doi: 10.1186/s12877-019-1086-2.

6.

Lineage choice decisions in B-cell development and leukemia.

Raboso-Gallego J, Casado-García A, Rodríguez-Hernández G, Vicente-Dueñas C, Sánchez-García I.

Stem Cell Investig. 2018 Dec 7;5:46. doi: 10.21037/sci.2018.12.01. eCollection 2018. No abstract available.

7.

T-cell leukemogenesis is an inappropriate lineage decision-making process: implications for precision oncology.

Rodríguez-Hernández G, Bhatia S, Vicente-Dueñas C, Borkhardt A, Hauer J, Sánchez-García I.

Mol Cell Oncol. 2018 Aug 7;5(4):e1497860. doi: 10.1080/23723556.2018.1497860. eCollection 2018.

8.

Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia.

Vicente-Dueñas C, González-Herrero I, Sehgal L, García-Ramírez I, Rodríguez-Hernández G, Pintado B, Blanco O, Criado FJG, Cenador MBG, Green MR, Sánchez-García I.

Leukemia. 2019 Jan;33(1):249-278. doi: 10.1038/s41375-018-0192-z. Epub 2018 Jun 28. No abstract available.

9.

Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.

García-Ramírez I, Bhatia S, Rodríguez-Hernández G, González-Herrero I, Walter C, González de Tena-Dávila S, Parvin S, Haas O, Woessmann W, Stanulla M, Schrappe M, Dugas M, Natkunam Y, Orfao A, Domínguez V, Pintado B, Blanco O, Alonso-López D, De Las Rivas J, Martín-Lorenzo A, Jiménez R, García Criado FJ, García Cenador MB, Lossos IS, Vicente-Dueñas C, Borkhardt A, Hauer J, Sánchez-García I.

EMBO J. 2018 Jul 13;37(14). pii: e98783. doi: 10.15252/embj.201798783. Epub 2018 Jun 7.

10.

Epigenetic Priming in Cancer Initiation.

Vicente-Dueñas C, Hauer J, Cobaleda C, Borkhardt A, Sánchez-García I.

Trends Cancer. 2018 Jun;4(6):408-417. doi: 10.1016/j.trecan.2018.04.007. Review.

PMID:
29860985
11.

Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors.

Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H, Ernst T, Hochhaus A, Kornblau SM, Konopleva M, Pufall MA, Cazzaniga G, Liu GJ, Milne TA, Koeffler HP, Ross TS, Sánchez-García I, Borkhardt A, Yamamoto KR, Dickins RA, Graeber TG, Müschen M.

Nature. 2018 Jun;558(7711):E5. doi: 10.1038/s41586-018-0164-5.

12.

The Making of Leukemia.

González-Herrero I, Rodríguez-Hernández G, Luengas-Martínez A, Isidro-Hernández M, Jiménez R, García-Cenador MB, García-Criado FJ, Sánchez-García I, Vicente-Dueñas C.

Int J Mol Sci. 2018 May 17;19(5). pii: E1494. doi: 10.3390/ijms19051494. Review.

13.

Loss of Pax5 Exploits Sca1-BCR-ABLp190 Susceptibility to Confer the Metabolic Shift Essential for pB-ALL.

Martín-Lorenzo A, Auer F, Chan LN, García-Ramírez I, González-Herrero I, Rodríguez-Hernández G, Bartenhagen C, Dugas M, Gombert M, Ginzel S, Blanco O, Orfao A, Alonso-López D, Rivas JL, García-Cenador MB, García-Criado FJ, Müschen M, Sánchez-García I, Borkhardt A, Vicente-Dueñas C, Hauer J.

Cancer Res. 2018 May 15;78(10):2669-2679. doi: 10.1158/0008-5472.CAN-17-3262. Epub 2018 Feb 28.

14.

Modeling the process of childhood ETV6-RUNX1 B-cell leukemias.

Rodríguez-Hernández G, Schäfer D, Gavilán A, Vicente-Dueñas C, Hauer J, Borkhardt A, Sánchez-García I.

Oncotarget. 2017 Sep 27;8(60):102674-102680. doi: 10.18632/oncotarget.21281. eCollection 2017 Nov 24. Review.

15.

Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells.

Auer F, Ingenhag D, Pinkert S, Kracker S, Hacein-Bey-Abina S, Cavazzana M, Gombert M, Martin-Lorenzo A, Lin MH, Vicente-Dueñas C, Sánchez-García I, Borkhardt A, Hauer J.

Oncotarget. 2017 Sep 7;8(44):75797-75807. doi: 10.18632/oncotarget.20563. eCollection 2017 Sep 29.

16.

Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases.

Rodríguez-Hernández G, Hauer J, Martín-Lorenzo A, Schäfer D, Bartenhagen C, García-Ramírez I, Auer F, González-Herrero I, Ruiz-Roca L, Gombert M, Okpanyi V, Fischer U, Chen C, Dugas M, Bhatia S, Linka RM, Garcia-Suquia M, Rascón-Trincado MV, Garcia-Sanchez A, Blanco O, García-Cenador MB, García-Criado FJ, Cobaleda C, Alonso-López D, De Las Rivas J, Müschen M, Vicente-Dueñas C, Sánchez-García I, Borkhardt A.

Cancer Res. 2017 Aug 15;77(16):4365-4377. doi: 10.1158/0008-5472.CAN-17-0701. Epub 2017 Jun 19.

17.

Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation.

Boto C, Quartin E, Cai Y, Martín-Lorenzo A, Cenador MBG, Pinto S, Gupta R, Enver T, Sánchez-García I, Hong D, Pires das Neves R, Ferreira L.

Nat Commun. 2017 May 11;8:15204. doi: 10.1038/ncomms15204.

18.

Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.

García-Ramírez I, Tadros S, González-Herrero I, Martín-Lorenzo A, Rodríguez-Hernández G, Moore D, Ruiz-Roca L, Blanco O, Alonso-López D, Rivas JL, Hartert K, Duval R, Klinkebiel D, Bast M, Vose J, Lunning M, Fu K, Greiner T, Rodrigues-Lima F, Jiménez R, Criado FJG, Cenador MBG, Brindle P, Vicente-Dueñas C, Alizadeh A, Sánchez-García I, Green MR.

Blood. 2017 May 11;129(19):2645-2656. doi: 10.1182/blood-2016-08-733469. Epub 2017 Mar 13.

19.

Metabolic gatekeeper function of B-lymphoid transcription factors.

Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H, Ernst T, Hochhaus A, Kornblau SM, Konopleva M, Pufall MA, Cazzaniga G, Liu GJ, Milne TA, Koeffler HP, Ross TS, Sánchez-García I, Borkhardt A, Yamamoto KR, Dickins RA, Graeber TG, Müschen M.

Nature. 2017 Feb 23;542(7642):479-483. doi: 10.1038/nature21076. Epub 2017 Feb 13. Erratum in: Nature. 2018 Jun;558(7711):E5.

20.

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.

Robles EF, Mena-Varas M, Barrio L, Merino-Cortes SV, Balogh P, Du MQ, Akasaka T, Parker A, Roa S, Panizo C, Martin-Guerrero I, Siebert R, Segura V, Agirre X, Macri-Pellizeri L, Aldaz B, Vilas-Zornoza A, Zhang S, Moody S, Calasanz MJ, Tousseyn T, Broccardo C, Brousset P, Campos-Sanchez E, Cobaleda C, Sanchez-Garcia I, Fernandez-Luna JL, Garcia-Muñoz R, Pena E, Bellosillo B, Salar A, Baptista MJ, Hernandez-Rivas JM, Gonzalez M, Terol MJ, Climent J, Ferrandez A, Sagaert X, Melnick AM, Prosper F, Oscier DG, Carrasco YR, Dyer MJ, Martinez-Climent JA.

Nat Commun. 2016 Jun 14;7:11889. doi: 10.1038/ncomms11889.

21.

Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?

García-Ramírez I, Martín-Lorenzo A, González-Herrero I, Rodriguez-Hernández G, Vicente-Dueñas C, Sánchez-García I.

Int J Mol Sci. 2016 Jun 6;17(6). pii: E889. doi: 10.3390/ijms17060889. Review.

22.

Comparative dosimetry for children and rodents exposed to extremely low-frequency magnetic fields.

Gong Y, Capstick M, Dasenbrock C, Fedrowitz M, Cobaleda C, Sánchez-García I, Kuster N.

Bioelectromagnetics. 2016 Jul;37(5):310-22. doi: 10.1002/bem.21976. Epub 2016 May 13.

PMID:
27176719
23.

Extremely low-frequency magnetic fields and risk of childhood leukemia: A risk assessment by the ARIMMORA consortium.

Schüz J, Dasenbrock C, Ravazzani P, Röösli M, Schär P, Bounds PL, Erdmann F, Borkhardt A, Cobaleda C, Fedrowitz M, Hamnerius Y, Sanchez-Garcia I, Seger R, Schmiegelow K, Ziegelberger G, Capstick M, Manser M, Müller M, Schmid CD, Schürmann D, Struchen B, Kuster N.

Bioelectromagnetics. 2016 Apr;37(3):183-189. doi: 10.1002/bem.21963. Epub 2016 Mar 15.

PMID:
26991812
24.

GEMMs addressing Pax5 loss-of-function in childhood pB-ALL.

Auer F, Ingenhag D, Bhatia S, Enczmann J, Cobaleda C, Sanchez-Garcia I, Borkhardt A, Hauer J.

Eur J Med Genet. 2016 Mar;59(3):166-72. doi: 10.1016/j.ejmg.2015.11.009. Epub 2015 Nov 26. Review.

PMID:
26626503
25.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

26.

Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?

Brown G, Sanchez-Garcia I.

Oncotarget. 2015 Dec 22;6(41):43326-41. doi: 10.18632/oncotarget.6145. Review.

27.

Infection causes childhood leukemia.

Hauer J, Martín-Lorenzo A, Sánchez-García I.

Aging (Albany NY). 2015 Sep;7(9):607-8. No abstract available.

28.

Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility.

Martín-Lorenzo A, Hauer J, Vicente-Dueñas C, Auer F, González-Herrero I, García-Ramírez I, Ginzel S, Thiele R, Constantinescu SN, Bartenhagen C, Dugas M, Gombert M, Schäfer D, Blanco O, Mayado A, Orfao A, Alonso-López D, Rivas Jde L, Cobaleda C, García-Cenador MB, García-Criado FJ, Sánchez-García I, Borkhardt A.

Cancer Discov. 2015 Dec;5(12):1328-43. doi: 10.1158/2159-8290.CD-15-0892. Epub 2015 Sep 25.

29.

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.

Misiewicz-Krzeminska I, Sarasquete ME, Vicente-Dueñas C, Krzeminski P, Wiktorska K, Corchete LA, Quwaider D, Rojas EA, Corral R, Martín AA, Escalante F, Bárez A, García JL, Sánchez-García I, García-Sanz R, San Miguel JF, Gutiérrez NC.

Clin Cancer Res. 2016 Jan 1;22(1):207-17. doi: 10.1158/1078-0432.CCR-14-2796. Epub 2015 Sep 4.

30.

How tumour cell identity is established?

Sánchez-García I.

Semin Cancer Biol. 2015 Jun;32:1-2. doi: 10.1016/j.semcancer.2015.04.004. Epub 2015 Apr 28. No abstract available.

PMID:
25931389
31.

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S.

Semin Cancer Biol. 2015 Dec;35 Suppl:S25-S54. doi: 10.1016/j.semcancer.2015.02.006. Epub 2015 Apr 17. Review.

32.

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.

Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Dueñas C, Romero-Camarero I, Sanchez-Garcia I, Plevritis SK, Arber DA, Batzoglou S, Levy R, Alizadeh AA.

Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1116-25. doi: 10.1073/pnas.1501199112. Epub 2015 Feb 23.

33.

Knowledge, Attitude and Use of Evidence-Based Practice among nurses active on the Internet.

Pérez-Campos MA, Sánchez-García I, Pancorbo-Hidalgo PL.

Invest Educ Enferm. 2014;32(3):451-60. doi: 10.17533/udea.iee.v32n3a10.

PMID:
25504411
34.

Genetically engineered mouse models of human B-cell precursor leukemias.

Hauer J, Borkhardt A, Sánchez-García I, Cobaleda C.

Cell Cycle. 2014;13(18):2836-46. doi: 10.4161/15384101.2014.949137. Review.

35.

[Growth hormone deficiency secondary to pituitary iron deposition in a pyruvate kinase deficient patient].

García García-Doncel L, Triviño Ibáñez EM, Sánchez García I, Baena Nieto G.

Med Clin (Barc). 2015 Jun 22;144(12):573-4. doi: 10.1016/j.medcli.2014.09.002. Epub 2014 Nov 24. Spanish. No abstract available.

PMID:
25441020
36.

Early epigenetic cancer decisions.

Martín-Lorenzo A, Gonzalez-Herrero I, Rodríguez-Hernández G, García-Ramírez I, Vicente-Dueñas C, Sánchez-García I.

Biol Chem. 2014 Nov 1;395(11):1315-20. doi: 10.1515/hsz-2014-0185. Review.

37.

Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.

Green MR, Vicente-Dueñas C, Romero-Camarero I, Long Liu C, Dai B, González-Herrero I, García-Ramírez I, Alonso-Escudero E, Iqbal J, Chan WC, Campos-Sanchez E, Orfao A, Pintado B, Flores T, Blanco O, Jiménez R, Martínez-Climent JA, Criado FJ, Cenador MB, Zhao S, Natkunam Y, Lossos IS, Majeti R, Melnick A, Cobaleda C, Alizadeh AA, Sánchez-García I.

Nat Commun. 2014 Jun 2;5:3904. doi: 10.1038/ncomms4904.

38.

Hit-and-run lymphomagenesis by the Bcl6 oncogene.

Green MR, Vicente-Dueñas C, Alizadeh AA, Sánchez-García I.

Cell Cycle. 2014;13(12):1831-2. doi: 10.4161/cc.29326. Epub 2014 May 27. No abstract available.

39.

Lineage-specific function of Engrailed-2 in the progression of chronic myelogenous leukemia to T-cell blast crisis.

Abollo-Jiménez F, Campos-Sánchez E, Toboso-Navasa A, Vicente-Dueñas C, González-Herrero I, Alonso-Escudero E, González M, Segura V, Blanco O, Martínez-Climent JA, Sánchez-García I, Cobaleda C.

Cell Cycle. 2014;13(11):1717-26. doi: 10.4161/cc.28629. Epub 2014 Mar 25.

40.

Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.

Vicente-Dueñas C, Hauer J, Ruiz-Roca L, Ingenhag D, Rodríguez-Meira A, Auer F, Borkhardt A, Sánchez-García I.

Semin Cancer Biol. 2015 Jun;32:3-9. doi: 10.1016/j.semcancer.2014.02.001. Epub 2014 Feb 12. Review.

PMID:
24530939
41.

Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.

Mainardi S, Mijimolle N, Francoz S, Vicente-Dueñas C, Sánchez-García I, Barbacid M.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):255-60. doi: 10.1073/pnas.1320383110. Epub 2013 Dec 23.

42.

[Obstacles perceived by nurses for evidence-based practice: a qualitative study].

Sánchez-García I, López-Medina IM, Pancorbo-Hidalgo PL.

Enferm Clin. 2013 Nov-Dec;23(6):279-83. doi: 10.1016/j.enfcli.2013.09.001. Epub 2013 Oct 11. Spanish.

PMID:
24125917
43.

[Assessment of the professional practice environment by Spanish nurses who participate in Internet forums].

Pérez-Campos MA, Sánchez-García I, Pancorbo-Hidalgo PL.

Enferm Clin. 2013 Nov-Dec;23(6):271-8. doi: 10.1016/j.enfcli.2013.07.004. Epub 2013 Sep 26. Spanish.

PMID:
24076320
44.

Genetic background affects susceptibility to tumoral stem cell reprogramming.

García-Ramírez I, Ruiz-Roca L, Martín-Lorenzo A, Blanco O, García-Cenador MB, García-Criado FJ, Vicente-Dueñas C, Sánchez-García I.

Cell Cycle. 2013 Aug 1;12(15):2505-9. doi: 10.4161/cc.25544. Epub 2013 Jul 8.

45.

CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage.

González-Herrero I, Romero-Camarero I, Cañueto J, Cardeñoso-Álvarez E, Fernández-López E, Pérez-Losada J, Sánchez-García I, Román-Curto C.

Br J Dermatol. 2013 Oct;169(4):830-7. doi: 10.1111/bjd.12428.

PMID:
23662851
46.

Function of oncogenes in cancer development: a changing paradigm.

Vicente-Dueñas C, Romero-Camarero I, Cobaleda C, Sánchez-García I.

EMBO J. 2013 May 29;32(11):1502-13. doi: 10.1038/emboj.2013.97. Epub 2013 Apr 30. Review.

47.

Back to the beginning: The initiation of cancer.

Cobaleda C, Sánchez-García I.

Bioessays. 2013 May;35(5):413. doi: 10.1002/bies.201300024. Epub 2013 Apr 2. No abstract available.

48.

Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation.

Romero-Camarero I, Jiang X, Natkunam Y, Lu X, Vicente-Dueñas C, Gonzalez-Herrero I, Flores T, Garcia JL, McNamara G, Kunder C, Zhao S, Segura V, Fontan L, Martínez-Climent JA, García-Criado FJ, Theis JD, Dogan A, Campos-Sánchez E, Green MR, Alizadeh AA, Cobaleda C, Sánchez-García I, Lossos IS.

Nat Commun. 2013;4:1338. doi: 10.1038/ncomms2334.

49.

p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice.

Velasco-Hernández T, Vicente-Dueñas C, Sánchez-García I, Martin-Zanca D.

Cell Cycle. 2013 Jan 1;12(1):122-32. doi: 10.4161/cc.23031. Epub 2012 Dec 19.

50.

Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.

Vicente-Dueñas C, González-Herrero I, García Cenador MB, García Criado FJ, Sánchez-García I.

Cell Cycle. 2012 Oct 15;11(20):3896-900. doi: 10.4161/cc.22186. Epub 2012 Sep 14.

Supplemental Content

Loading ...
Support Center